Perioperative & Surgical Care

Necrotizing soft tissue infection: surgical management

Clinical Overview and When to Suspect Necrotizing Soft Tissue Infection

— Type I (polymicrobial, ~70–80%): mixed aerobes/anaerobes; diabetics, postoperative, perineal/abdominal sources, immunocompromised.

— Type II (monomicrobial): Group A Strep ± Staph aureus (including MRSA); healthy young adults after minor trauma, IVDU, varicella.

— Type III: Vibrio vulnificus (warm saltwater, oyster ingestion, cirrhosis), Aeromonas (freshwater).

— Type IV: fungal (Mucor, Candida) in immunocompromised or post-trauma.

— Pain out of proportion to exam findings

— Rapidly spreading erythema with systemic toxicity (fever, tachycardia, hypotension, confusion)

— Skin findings: bullae (especially hemorrhagic), crepitus, dusky/violaceous skin, anesthesia over involved area (nerve infarction), "dishwater" gray drainage

— Risk factors: DM, PVD, cirrhosis, IVDU, immunosuppression, recent surgery, perineal abscess, saltwater/oyster exposure

Board pearl: The classic exam stem couples a "benign-looking" cellulitis with severe pain, tachycardia out of proportion, and a lactate of 4 — this is NSTI until proven otherwise, and the next best step is surgical consultation for OR debridement, not MRI.

Step 3 management: Do not delay debridement for imaging in a hemodynamically unstable patient with a high LRINEC or clinical NSTI — imaging is for ambiguous cases only.

Definition: Rapidly progressive infection of subcutaneous tissue, fascia, and/or muscle with thrombosis of perforating vessels causing tissue necrosis. Umbrella term covers necrotizing fasciitis, Fournier gangrene (perineum), Ludwig angina (submandibular), clostridial myonecrosis (gas gangrene), and Vibrio/Aeromonas infections.

Microbiologic classes:

When to suspect on Step 3:

Mortality: 20–40% overall; >50% if surgery delayed >24 hours. Time-to-debridement is the single strongest modifiable predictor of survival.

Presentation Patterns and Key History

— Hours 0–24: localized pain, mild erythema, often mistaken for cellulitis or DVT

— Hours 24–72: skin changes (bullae, dusky discoloration), systemic toxicity, anesthesia over lesion

— Hours 72+: frank necrosis, septic shock, multiorgan failure

— Fournier gangrene: scrotal/perineal pain in diabetic or obese male; source often perirectal abscess, urethral stricture, or postsurgical. Females can be affected (Bartholin abscess, episiotomy).

— Ludwig angina: bilateral submandibular swelling, "hot potato" voice, tongue elevation, dental source (2nd/3rd molar). Airway emergency.

— Cervical necrotizing fasciitis: odontogenic or pharyngeal source, can descend to mediastinum.

— Extremity NSTI: trauma, IVDU injection site, post-op wound.

— Vibrio vulnificus: cirrhotic patient ate raw oysters or waded in Gulf Coast water with open wound; bullous lesions on lower extremities within 24h.

— Speed of progression (hours vs days)

— Trauma, surgery, IV drug use, dental work

— Water/seafood exposure

— Immunosuppression: DM, cirrhosis, chemotherapy, HIV, chronic steroids

— NSAID use (controversial — may mask symptoms and is associated with GAS NSTI)

— Varicella in children → invasive GAS

Key distinction: Cellulitis has erythema proportional to pain and responds to IV antibiotics within 48h; NSTI has pain disproportional to skin findings and worsens despite antibiotics. Failure of cellulitis to improve in 24–48h should prompt re-evaluation for NSTI.

Temporal evolution (hours, not days):

Anatomic syndromes to recognize:

Key history questions:

Pain character: Severe, deep, often described as "worst pain of my life." Pain extending beyond visible erythema is a red flag. Later, anesthesia develops as cutaneous nerves infarct — a paradoxically "painless" area in a previously agonizing wound is ominous.

Physical Exam Findings and Hemodynamic Assessment

— Early: erythema, edema, warmth, tenderness extending beyond visible margins

— Intermediate: tense edema, skin discoloration (dusky, violaceous, bronze), serous/hemorrhagic bullae, induration with poorly demarcated borders

— Late: skin anesthesia, frank necrosis, crepitus (gas-producing organisms — clostridia, mixed anaerobes), "dishwater pus" drainage, malodorous discharge

— Hemorrhagic bullae

— Skin necrosis or anesthesia

— Crepitus

— Rapid progression despite antibiotics

— Systemic toxicity disproportionate to local findings

— Vitals: fever (or hypothermia — worse prognosis), tachycardia, hypotension, tachypnea

— qSOFA / SOFA scoring; lactate

— Mental status changes from sepsis or streptococcal toxic shock

— Toxic shock features in GAS NSTI: diffuse erythroderma, hypotension, multiorgan involvement

— Finger test (at bedside under local or in OR): 2-cm incision through skin; lack of bleeding, "dishwater" fluid, and easy finger dissection along fascia confirm NSTI

— Probe-to-bone or probe-to-fascia for perineal/extremity wounds

Board pearl: Crepitus is specific but insensitive — only ~30% of NSTI cases have palpable crepitus. Its absence does NOT rule out NSTI.

Step 3 management: In the ED, the moment hard signs appear or hemodynamic instability develops, call surgery and start resuscitation simultaneously — do not send to MRI. CCS clock: hour 0 IV access, lactate, blood cultures, broad antibiotics, fluids, surgical consult.

Cutaneous signs (progress in order):

"Hard signs" of NSTI:

Hemodynamic and systemic assessment:

Bedside maneuvers:

Compartment assessment: palpate for tense compartments; necrotizing myositis can mimic compartment syndrome.

Diagnostic Workup — Initial Labs, Imaging, Biomarkers

— CBC with diff (WBC often >15K, left shift; bandemia)

— BMP (Cr, glucose — DKA common trigger), lactate

— CRP (often >150 mg/L)

— CK (elevated in myonecrosis)

— Coags (DIC from sepsis)

— Blood cultures × 2 before antibiotics if it does not delay therapy

— Wound/tissue Gram stain and culture (intraoperative samples are gold standard)

— ABG, type and screen, lipase if abdominal source

— CRP ≥150 (4 pts), WBC 15–25 (1) or >25 (2), Hgb 11–13.5 (1) or <11 (2), Na <135 (2), Cr >1.6 (2), Glucose >180 (1)

— ≥6 = moderate risk; ≥8 = high risk

— Limitations: sensitivity ~60–70%; a low LRINEC does NOT rule out NSTI in a high-suspicion patient. Do not delay surgery for a "reassuring" score.

— Plain radiograph: subcutaneous gas (insensitive but specific)

— CT with contrast: fascial thickening, fat stranding, gas tracking along fascia, non-enhancing fascia, abscess — fastest, most practical

— MRI: most sensitive but slow; rarely appropriate acutely

— POCUS: cobblestoning, fluid along fascial planes ("STAFF" — Subcutaneous Thickening, Air, Fascial Fluid)

Key distinction: LRINEC and imaging are adjuncts, not gatekeepers. Surgical exploration is both diagnostic and therapeutic — the gold standard is operative findings (gray necrotic fascia, lack of bleeding, easy blunt dissection).

Board pearl: If the stem says "CT shows gas along the fascial planes" — stop reading and pick emergent surgical debridement.

Core labs (all NSTI suspects):

LRINEC score (Laboratory Risk Indicator for Necrotizing Fasciitis):

Imaging — only if diagnosis uncertain AND patient stable:

Biomarkers: procalcitonin can support sepsis but does not differentiate NSTI from severe cellulitis.

Diagnostic Workup — Advanced and Confirmatory Studies

— Findings: gray, necrotic fascia; lack of bleeding on dissection; "dishwater" exudate; muscle that does not contract or bleed (myonecrosis); easy separation of subcutaneous tissue from fascia with finger or blunt instrument

— Frozen-section histopathology can confirm in equivocal cases: PMN infiltration of deep fascia, fascial necrosis, microvascular thrombosis, bacteria on Gram stain

— Aerobic, anaerobic, fungal (in immunocompromised)

— Gram stain may show gram-positive cocci in chains (GAS), gram-positive rods (Clostridium), gram-negative curved rods (Vibrio), or mixed flora

— Pair tissue cultures with blood cultures; positive blood cultures in ~60% of monomicrobial cases

— GAS: chains of gram-positive cocci, toxic shock features → add clindamycin for toxin suppression, consider IVIG

— Clostridium perfringens: "boxcar" gram-positive rods, hemolysis, jaundice, profound tachycardia; abundant gas

— Vibrio vulnificus: comma-shaped gram-negative rods; doxycycline + ceftriaxone or cefotaxime

— Aeromonas hydrophila: freshwater exposure; ciprofloxacin + doxycycline

— Echocardiogram if persistent bacteremia or murmur (rule out endocarditis seeding)

— HIV testing in monomicrobial NSTI in young patient without obvious risk

— A1c, screen for new diabetes

CCS pearl: After initial debridement, schedule re-exploration within 12–24 hours and continue every 24–48h until no further necrosis. Order: "OR for repeat debridement in 24 hours" — this is a recurring task on the CCS case.

Board pearl: The MOST sensitive test for NSTI is surgical exploration — not MRI, not CT, not LRINEC.

Operative exploration = definitive diagnosis:

Tissue cultures:

Specific organism clues:

Additional workup:

Repeat imaging/exam: Not a substitute for serial OR explorations.

Risk Stratification and First-Line Management Logic

— Step 1: Resuscitate — 2 large-bore IVs, crystalloid 30 mL/kg for sepsis, vasopressors (norepinephrine first) if MAP <65 after fluids, central line if needed

— Step 2: Broad-spectrum empiric antibiotics within 1 hour

— Step 3: Emergent surgical consultation for OR debridement — goal door-to-OR <6 hours, ideally <3

— Step 4: ICU admission

— Step 5: Source control of any underlying focus (perirectal abscess, dental, urinary)

— Septic shock with NSTI: mortality 50–70%

— Clostridial myonecrosis: 25% mortality, faster progression

— Fournier gangrene: 20–40% mortality; FGSI score (similar to LRINEC) stratifies

— Vibrio NSTI in cirrhotic: >50% mortality

— Delay to first debridement (>24h doubles mortality)

— Inadequate first debridement (re-exploration is mandatory, not optional)

— Inappropriate empiric antibiotics (missing MRSA or anaerobes)

Step 3 management: The single best next step in a hemodynamically unstable patient with hard signs of NSTI is immediate surgical debridement — even before imaging, even before culture results, even before antibiotics fully infuse. Antibiotics and resuscitation occur in parallel during transport to OR.

CCS pearl: On CCS, simultaneously order: IV access × 2, NS bolus, blood cultures, lactate, CBC/BMP/coags, broad-spectrum antibiotics (vanc + pip-tazo + clindamycin), surgery consult STAT, ICU bed, NPO, type and cross. Move clock forward 1–2 hours; patient should be in OR.

Board pearl: "Antibiotics alone" is always wrong for NSTI on Step 3.

Decision framework (sequential, not parallel):

Risk stratification of severity:

Modifiable predictors of death:

Time-to-OR is the single most important quality metric.

Pharmacotherapy — First-Line Empiric Antibiotic Regimen

— Gram-positive incl. MRSA: Vancomycin 25–30 mg/kg load then 15–20 mg/kg q8–12h (target trough 15–20) OR linezolid 600 mg IV q12h (preferred if AKI or vancomycin allergy; also suppresses toxin production)

— Broad gram-negative + anaerobic: Piperacillin-tazobactam 4.5 g IV q6–8h OR meropenem 1 g IV q8h (use carbapenem if recent broad-spectrum exposure, ESBL risk, or severe sepsis)

— Toxin/protein synthesis suppression: Clindamycin 900 mg IV q8h — critical for GAS and clostridial NSTI; suppresses exotoxin production (M protein, streptolysins, alpha toxin). Continue until clinical improvement and no toxic shock features (~48–72h).

— Beta-lactams are less effective against high-inoculum GAS in stationary phase; clindamycin is concentration-independent and inhibits ribosomal protein synthesis, halting toxin production regardless of bacterial growth phase

— Linezolid is an acceptable alternative (also a protein synthesis inhibitor)

— Confirmed GAS monomicrobial: penicillin G 4 MU IV q4h + clindamycin

— Clostridial myonecrosis: penicillin G + clindamycin

— Vibrio vulnificus: doxycycline 100 mg IV q12h + ceftriaxone 1–2 g IV q24h (or cefotaxime); fluoroquinolone alternative

— Aeromonas: ciprofloxacin + doxycycline

— MRSA confirmed: continue vancomycin or switch to linezolid/daptomycin

Board pearl: The classic Step 3 wrong answer is "pip-tazo + vancomycin" without clindamycin — always add clindamycin for empiric NSTI coverage.

Key distinction: Clindamycin is added for toxin suppression, not anaerobic coverage (pip-tazo already covers anaerobes).

Empiric triple coverage (start within 1 hour):

Why clindamycin matters (the "Eagle effect"):

Pathogen-specific adjustments after cultures:

Duration: Continue IV antibiotics until source controlled, patient afebrile, hemodynamically stable, and no further debridement needed — typically 10–14 days, longer with bacteremia or endocarditis.

Surgical Management — The Cornerstone

— Aggressive, wide debridement to bleeding viable tissue along all planes of involvement

— Resect all necrotic fascia, fat, and muscle; do NOT spare based on cosmesis

— Leave wounds open with moist dressings (saline-soaked gauze or NPWT after stabilization)

— Send multiple tissue specimens for Gram stain, aerobic/anaerobic/fungal cultures, and histopathology

— Mark margins; photograph if institutional protocol

— Return to OR within 12–24 hours for second-look debridement

— Continue every 24–48 hours until no further necrosis at two consecutive operations

— Average patient requires 3–5 debridements

— Fournier gangrene: debride perineum, scrotum (testes usually spared — separate blood supply from spermatic cord); diverting colostomy if fecal contamination or perineal involvement extensive; suprapubic catheter if urethral involvement

— Extremity NSTI: amputation if life-threatening sepsis, extensive myonecrosis, or non-salvageable limb — do not delay for limb preservation when life is at stake

— Cervical/Ludwig: secure airway first (awake fiberoptic intubation or surgical airway); drainage of all involved fascial spaces

— Hyperbaric oxygen (HBO): controversial; may benefit clostridial myonecrosis if available without delaying surgery; never substitute for debridement

— IVIG: consider for streptococcal toxic shock with NSTI (2 g/kg single dose or divided); neutralizes superantigens

— NPWT (wound VAC): after acute phase, to manage large defects and prepare for reconstruction

CCS pearl: Order set: "OR for surgical debridement" → repeat at 24 hours → ICU postop → daily wound checks → plastics/urology consult for reconstruction.

Board pearl: Source control trumps everything. No antibiotic, HBO, or IVIG salvages an under-debrided wound.

Operative principles:

Mandatory re-exploration:

Anatomic considerations:

Adjuncts:

Reconstruction: split-thickness skin grafts, flaps, or staged closure after infection controlled.

Special Populations — Elderly and Renal/Hepatic Impairment

— Higher baseline mortality (40–60%); blunted febrile response; often present late

— Comorbidities (DM, PVD, CKD, CHF) limit resuscitation tolerance

— Goals-of-care discussion should occur early — ideally before first OR — given high mortality and morbidity (amputation, prolonged ICU, disability)

— Functional status pre-illness strongly predicts recovery; involve geriatrics, palliative care

— Sepsis-associated AKI is common; adjust dosing:

– Vancomycin: pharmacy-driven AUC dosing; trough monitoring

– Pip-tazo: extend interval (q8h or q12h based on CrCl); consider meropenem if CRRT

– Linezolid: no renal adjustment (preferred in AKI)

– Clindamycin: no renal adjustment

– Daptomycin: q48h if CrCl <30

— Contrast caution for CT — but do not withhold imaging when needed in unstable septic patient; AKI from sepsis far outweighs contrast risk

— CRRT often required; coordinate antibiotic dosing with nephrology

— Massively increased risk for Vibrio vulnificus NSTI — counsel patients to avoid raw oysters and saltwater wounds

— Coagulopathy complicates surgery; correct INR with vitamin K, FFP, or factor concentrates; platelets if <50K for OR

— Avoid hepatotoxic antibiotics where possible; clindamycin hepatic dose adjustment in severe disease

— Higher mortality (>50%); SBP, variceal bleeding may co-occur

— Most common comorbidity in NSTI (especially Fournier, polymicrobial)

— Aggressive glucose control (target 140–180 mg/dL in ICU); insulin drip for DKA/HHS

— Screen all NSTI patients for new-onset DM (A1c)

Step 3 management: In an elderly cirrhotic with septic shock from NSTI, early goals-of-care conversation with family before second debridement is both ethically appropriate and frequently tested.

Board pearl: Cirrhosis + raw oysters + bullous skin lesions = Vibrio vulnificus — empiric doxycycline + ceftriaxone in addition to standard NSTI coverage.

Elderly patients:

Renal impairment / AKI:

Hepatic impairment / cirrhosis:

Diabetes:

Special Populations — Pregnancy, Pediatrics, and Other Subgroups

— Rare but devastating; sources include episiotomy, C-section wound, chorioamnionitis spread, perineal trauma

— Resuscitation and surgery take priority over fetal concerns; maternal survival = fetal survival

— Antibiotic choices: pip-tazo (category B), vancomycin (B), clindamycin (B) all acceptable; avoid doxycycline (teratogenic, bone/teeth) and fluoroquinolones when alternatives exist

— For Vibrio in pregnancy: ceftriaxone monotherapy or with azithromycin

— Imaging: MRI preferred over CT if time allows; otherwise CT with appropriate shielding — do not delay

— Multidisciplinary: OB, surgery, MFM, NICU

— Often follows varicella (chickenpox) with secondary GAS infection — vaccination has dramatically reduced incidence

— Omphalitis in neonates can progress to abdominal wall NSTI

— Weight-based dosing: vancomycin 15 mg/kg q6h, clindamycin 10–13 mg/kg q8h, pip-tazo 100 mg/kg q8h

— Consider IVIG for streptococcal toxic shock

— Long-term: scarring, contracture, psychological impact; involve child life, PT/OT

— Broader pathogen spectrum — consider fungal (Mucor, Candida) and atypical organisms

— Add antifungal (liposomal amphotericin B or echinocandin) empirically if high suspicion

— Lower threshold for surgery; may have blunted inflammatory response

— Subcutaneous "skin popping" → polymicrobial NSTI, often anaerobic

— Screen for HIV, HCV, endocarditis; consider MAT (buprenorphine/methadone) referral during admission

— Address pain control with addiction medicine input

Board pearl: Child with chickenpox who develops worsening pain and fever 3–5 days into illness with rapidly spreading erythema → invasive GAS NSTI — emergent surgery and clindamycin.

Step 3 management: In pregnancy, maternal stabilization always precedes fetal monitoring decisions — do not delay surgery for OB workup.

Pregnancy:

Pediatrics:

Immunocompromised (chemotherapy, transplant, HIV):

IV drug users:

Complications and Adverse Outcomes

— Septic shock and multiorgan failure: AKI, ARDS, DIC, hepatic dysfunction; ICU mortality 30–50%

— Streptococcal toxic shock syndrome (STSS): hypotension + multiorgan involvement from superantigen-mediated cytokine storm; mortality 30–70%

— Bacteremia and metastatic infection: endocarditis, septic emboli, vertebral osteomyelitis

— Compartment syndrome from extensive edema — may require fasciotomy

— Death: overall 20–40%, higher with delay, comorbidities, Vibrio, clostridial

— Bleeding from debrided beds; coagulopathy from DIC or cirrhosis

— Wound dehiscence, enterocutaneous fistula (especially after Fournier with bowel involvement)

— Need for diverting colostomy in 20–40% of Fournier cases

— Amputation in 15–30% of extremity NSTI

— Massive tissue loss → reconstructive burden (grafts, flaps), prolonged hospitalization

— Chronic pain, contractures, lymphedema, disfigurement

— Sexual dysfunction (Fournier), urinary/fecal incontinence

— Heterotopic ossification, scar hypertrophy

— Post-ICU syndrome: cognitive impairment, PTSD, depression, ICU-acquired weakness

— Psychosocial: body image disturbance, return-to-work disability

Key distinction: Mortality is driven by time-to-debridement and host factors, not antibiotic choice — though clindamycin/IVIG meaningfully improve STSS outcomes.

Board pearl: A patient with NSTI who develops new hypotension, oliguria, and rash on day 2 — think streptococcal toxic shock from inadequate source control. Next step: return to OR, ensure clindamycin, consider IVIG.

CCS pearl: Watch for secondary deterioration after initial improvement — this signals missed necrosis, abscess, or new compartment involvement. Re-explore.

Acute complications:

Surgical complications:

Late and chronic complications:

Recurrence: uncommon in same site, but underlying conditions (DM, IVDU, cirrhosis) predispose to future infections.

When to Escalate Care — ICU, Consult, Inpatient Triage

— Hemodynamic monitoring, vasopressors, ventilator readiness, CRRT capability

— Hourly urine output, lactate clearance, serial exams

— Multidisciplinary daily rounds

— Surgery (general, urology for Fournier, ENT/OMFS for Ludwig, plastics for reconstruction) — STAT, in person, not virtual

— Infectious disease for antibiotic stewardship and unusual pathogens

— Critical care / intensivist

— Anesthesia for OR planning

— Lack of 24/7 surgical capability, ICU, or interventional support → transfer to tertiary center — but do not delay initial debridement if local surgeon can perform

— EMTALA: stabilize first (resuscitation, antibiotics, initial debridement if necessary) before transfer; accepting facility must agree

— Burn center transfer occasionally appropriate for extensive soft tissue loss

— Rising lactate or vasopressor requirement → return to OR for missed necrosis

— New organ dysfunction → reassess source control

— Persistent fever >72h despite appropriate antibiotics → imaging for undrained collection, reculture

— Coagulopathy or DIC → blood product support, ICU

— Hemodynamically stable off pressors >24h

— Afebrile, declining WBC, lactate normalized

— No further necrosis on two consecutive debridements

— Then: transition to step-down, narrow antibiotics, plan reconstruction

Step 3 management: The single most important early escalation step in NSTI is immediate surgical consult plus ICU admission — both, not either/or. Failure to consult surgery promptly is the most-tested error.

CCS pearl: Order "transfer to ICU" and "surgery consult, STAT" in the first 30 minutes of the case; deferring either loses points.

All NSTI patients require ICU-level care:

Mandatory consults (day 0):

Transfer criteria:

Day-by-day escalation triggers:

De-escalation criteria:

Key Differentials — Same-Category Soft Tissue Infections

— Erythema, warmth, tenderness without deep tissue involvement

— Pain proportional to exam; no bullae, crepitus, or systemic toxicity

— Responds to IV antibiotics within 48h (e.g., cefazolin, vancomycin if MRSA risk)

— LRINEC low; no fascial changes on imaging

— If not improving in 48h → reconsider NSTI

— Sharply demarcated, raised, fiery red plaque; typically face or lower leg

— Almost always GAS; lymphatic involvement

— Treat with penicillin or cephalosporin; no surgical role

— Fluctuant collection, often MRSA; treated with I&D ± antibiotics

— No fascial involvement; no systemic toxicity unless complicated

— Primary muscle abscess (S. aureus typically), often tropical or immunocompromised

— MRI shows muscle abscess without fascial necrosis

— Drainage + antibiotics; usually does not require radical debridement

— A subset of NSTI — muscle-predominant, rapid, severe; same management principles (emergent debridement, pen G + clindamycin)

— Slow, chronic ulcer with peripheral undermining; not the same emergency

— Polymicrobial; debridement + antibiotics

— Localized to bursa/tendon sheath; pain with passive motion (Kanavel signs in flexor tenosynovitis)

— Surgical drainage but more limited

Key distinction: The single feature separating NSTI from severe cellulitis is rapidly progressive systemic toxicity with pain disproportionate to exam — this should trigger surgical consultation regardless of imaging.

Board pearl: A patient with "cellulitis" failing 48 hours of appropriate IV antibiotics is NSTI until proven otherwise — order CT and call surgery, do not just broaden antibiotics.

Cellulitis:

Erysipelas:

Cutaneous abscess:

Pyomyositis:

Gas gangrene (clostridial myonecrosis):

Synergistic gangrene (Meleney):

Septic bursitis or tenosynovitis:

Key Differentials — Other-Category Mimics

— Unilateral leg swelling, warmth, erythema; rule out with duplex US

— No systemic toxicity unless PE; no skin necrosis

— Mimics extremity NSTI early

— Pain out of proportion, paresthesia, pallor, paralysis, pulselessness (late)

— Pressure measurement >30 mmHg or ΔP <30 — fasciotomy

— Can coexist with NSTI; if both, fasciotomy AND debridement

— Painful ulcer with violaceous undermined border, often in IBD or rheumatologic disease

— Pathergy — worsens with debridement (key distinction)

— Treat with steroids/immunosuppression, NOT surgery

— ESRD patient with painful violaceous skin lesions, necrosis on lower extremities/abdomen

— Vascular calcification; treat with sodium thiosulfate, parathyroidectomy considerations

— Not infectious; surgery worsens it

— Anticoagulant exposure history; characteristic distribution (breasts, thighs)

— Treat with anticoagulation reversal/switch, not debridement

— Exposure history; localized necrosis without systemic sepsis (usually)

— Supportive care, antivenom for snakes; limited debridement

— Purpura, ulcerations; systemic features; serologies

— Immunosuppression, not surgery

Key distinction: Pyoderma gangrenosum worsens with debridement — if the stem mentions IBD or RA with an ulcer that grew after surgery, think PG, not NSTI. Biopsy edges, treat with steroids.

Board pearl: Always check anticoagulation history and dialysis status before assuming necrotic skin is NSTI — warfarin necrosis and calciphylaxis are surgical traps.

Deep vein thrombosis (DVT):

Compartment syndrome:

Pyoderma gangrenosum:

Calciphylaxis:

Warfarin-induced skin necrosis / heparin-induced thrombocytopenia:

Necrotic envenomation (brown recluse, snake):

Vasculitis (cryoglobulinemia, ANCA):

Secondary Prevention, Discharge Medications, and Long-Term Plan

— Complete IV antibiotic course (typically 10–14 days, longer if bacteremia/endocarditis)

— Transition to oral antibiotics only after definitive source control, afebrile, declining inflammatory markers, and reliable enteral absorption

— Common PO step-downs: amoxicillin-clavulanate, doxycycline, linezolid, TMP-SMX, depending on culture results

— PICC line for outpatient parenteral antibiotic therapy (OPAT) if prolonged IV needed

— Home health for dressing changes or wound clinic follow-up

— NPWT (wound VAC) continuation if applicable

— Reconstructive surgery scheduled (skin grafts, flaps) once wound bed clean

— Colostomy/urostomy education if applicable

— Diabetes: intensify glycemic control (A1c <7%, individualized); insulin teaching; podiatry for foot care

— Cirrhosis: counsel against raw shellfish/saltwater wounds; hepatology follow-up

— IVDU: MAT initiation, addiction medicine, syringe service referral, naloxone prescription

— Peripheral vascular disease: vascular surgery referral, smoking cessation, statin, antiplatelet

— Immunosuppression: review medication doses, vaccination status

— Pneumococcal (PCV20 or PCV15 + PPSV23), influenza, COVID-19, tetanus/Tdap (especially if not current), HBV in IVDU/cirrhosis

— VTE prophylaxis during hospitalization; consider extended prophylaxis if prolonged immobility

Step 3 management: Discharge from NSTI is a transitions-of-care minefield — coordinate OPAT, wound clinic, primary care, specialty follow-up, and pharmacy reconciliation before patient leaves. A failed handoff is a tested patient safety failure.

Board pearl: Always address the underlying driver (DM, IVDU, cirrhosis) — treating only the wound misses the most important secondary prevention step.

Inpatient transition to discharge:

Wound care plan:

Address underlying risk factors:

Vaccinations before discharge:

Anticoagulation:

Mental health: screen for depression, PTSD, body image concerns; psychiatry referral as needed.

Follow-Up, Monitoring Parameters, Rehab and Counseling

— Wound clinic / surgery: within 1 week, then weekly until healed

— Primary care: within 1–2 weeks for medication reconciliation, comorbidity management

— Infectious disease: midway through antibiotic course and at completion

— Plastics/reconstruction: timing based on wound readiness (usually 4–8 weeks)

— Urology (Fournier): catheter management, sexual function counseling

— Specialty follow-up: endocrinology (DM), hepatology (cirrhosis), vascular, addiction medicine

— Weekly CBC, BMP, LFTs while on IV antibiotics

— Vancomycin trough or AUC weekly; renal function

— CRP/ESR trend (not always necessary)

— Specific monitoring: linezolid → weekly CBC for thrombocytopenia; daptomycin → weekly CK; aminoglycosides → trough/peak, audiometry

— Physical therapy: early mobilization, strength, contracture prevention; critical after ICU stay (ICU-acquired weakness affects >50%)

— Occupational therapy: ADL retraining, especially after upper extremity involvement or amputation

— Prosthetics: referral early if amputation; phantom limb pain management

— Lymphedema therapy for extremity involvement

— Wound care technique, signs of recurrence/infection (return precautions)

— Diet (protein for wound healing, glycemic control)

— Smoking cessation

— Sexual function and pelvic floor PT (Fournier patients)

— Return to work timeline; disability paperwork

— Mental health resources; support groups

CCS pearl: On simulated cases, schedule wound clinic at 1 week, PCP at 2 weeks, ID at 4 weeks, and order home health for dressing changes — these tasks accumulate completeness points.

Board pearl: Vaccination for invasive GAS does not exist; secondary prevention focuses on host factors. Antibiotic prophylaxis for household contacts of invasive GAS is considered in selected high-risk contacts (CDC guidance).

Post-discharge schedule:

Monitoring labs during OPAT:

Rehabilitation:

Counseling topics:

Quality measures: 30-day readmission rate, surgical site infection rate, time-to-OR.

Ethical, Legal, and Patient Safety Considerations

— NSTI patients are often septic, encephalopathic, or hypotensive — unable to consent

— Emergency exception (implied consent) applies when life or limb is at immediate risk and no surrogate is reachable; document attempts to contact family

— When surrogate available, obtain telephone consent with witness for surgery, including potential amputation, colostomy, fasciotomy, and need for repeated procedures

— Discuss prognosis, mortality risk, and reasonable goals upfront

— Mortality 20–50%; functional outcomes often poor in elderly/comorbid patients

— Early palliative care consult is not abandoning curative care — it supports symptom management and complex decision-making

— Document a meeting with family/surrogate before second debridement if patient remains unstable or non-progressing

— Invasive group A streptococcal disease is reportable in many states; notify public health

— Vibrio vulnificus often reportable

— Document exposure history for outbreak investigation

— Door-to-OR time is a publicly tracked quality metric; document timeline meticulously

— Antibiotic stewardship: de-escalate based on cultures

— Falls, pressure injuries, VTE prophylaxis, glycemic control, delirium prevention (CAM-ICU)

— Handoff failures at shift change and transfer are the #1 source of safety events in critical surgical patients — use structured SBAR

— Wound photographs in chart can prevent communication errors

— Missed or delayed diagnosis of NSTI is a leading malpractice claim — early surgical consultation is both clinically and medicolegally protective

— If diagnostic delay occurred, disclose honestly to patient/family per institutional policy

Step 3 management: When an obtunded NSTI patient needs emergent surgery and family cannot be reached, proceed under emergency consent and document attempts — delaying surgery to find a surrogate is the wrong answer.

Board pearl: Failure to consult surgery promptly in suspected NSTI is the most-litigated decision; reflexive early surgical involvement is the safest practice.

Informed consent in the unstable patient:

Goals of care and palliative integration:

Mandatory reporting and public health:

Patient safety priorities:

Disclosure of adverse events:

High-Yield Associations and Rapid-Fire Clinical Facts

— Diabetes + perineal pain → Fournier gangrene

— Cirrhosis + raw oysters/saltwater → Vibrio vulnificus

— Freshwater laceration → Aeromonas hydrophila

— Varicella + worsening pain → invasive GAS NSTI

— IVDU "skin popping" → polymicrobial NSTI

— Dental abscess + neck swelling → Ludwig angina

— Post-trauma with farm/soil → Clostridium perfringens

— Post-C-section/episiotomy → polymicrobial pelvic NSTI

— Clindamycin suppresses toxin production (Eagle effect)

— Linezolid alternative for toxin suppression; preferred in AKI

— Doxycycline + ceftriaxone for Vibrio

— IVIG for streptococcal toxic shock

— Avoid NSAIDs (mask symptoms; possibly worsen GAS infection)

— Gas on plain film = specific, insensitive

— CT: fascial thickening, fat stranding, gas, non-enhancement

— MRI most sensitive but rarely justifies delay

— LRINEC ≥6 moderate, ≥8 high risk; low score does NOT rule out

— FGSI for Fournier severity

— Time-to-debridement <6h ideal; <24h critical

— Plan for 3–5 OR trips

— Testes spared in Fournier (separate blood supply)

— Diverting colostomy for extensive perineal involvement

— Amputate if life > limb

Board pearl: When the stem includes "pain out of proportion" + any systemic toxicity sign, the answer is emergent surgical consultation and broad-spectrum antibiotics + clindamycin — almost regardless of other details.

Key distinction: Mortality is determined by time and source control, not antibiotic sophistication.

Trigger associations:

Drug pearls:

Imaging pearls:

Score pearls:

Surgical pearls:

Mortality drivers: delay to surgery, age, comorbidities (cirrhosis, DM, immunosuppression), shock at presentation, Vibrio/clostridial etiology

Adjunct pearls: HBO controversial; never delays surgery. IVIG for STSS, not all NSTI.

Vaccine pearl: Varicella vaccine has reduced pediatric GAS NSTI substantially.

Board Question Stem Patterns

— Stem: "60yo diabetic with 12 hours of severe leg pain, mild erythema, T 39, HR 130, BP 88/50, lactate 5, WBC 22K." Next step?

— Answer: Surgical consultation for emergent debridement + IV vancomycin + pip-tazo + clindamycin + fluid resuscitation. Distractors: MRI, IV antibiotics alone, dermatology consult.

— Stem: Obese diabetic male with scrotal pain, crepitus, fever, foul-smelling discharge.

— Answer: Emergent surgical debridement + broad antibiotics; consider diverting colostomy; urology consult.

— Stem: Cirrhotic patient ate raw oysters 24h ago, now with bullous lesions on legs and shock.

— Answer: Doxycycline + ceftriaxone + emergent debridement.

— Stem: 5yo with chickenpox develops worsening leg pain and fever day 4.

— Answer: Invasive GAS NSTI → OR + penicillin G + clindamycin ± IVIG.

— Stem: Patient on 48h of IV cefazolin for "cellulitis" now has bullae and hypotension.

— Answer: Re-evaluate for NSTI → surgical consultation, broaden antibiotics, add clindamycin.

— Stem: Unstable patient, surgeon wants to operate but ED orders MRI.

— Answer: Proceed to OR; do not delay for MRI.

— Stem: Vancomycin + pip-tazo started; what is missing?

— Answer: Clindamycin for toxin suppression.

— Stem: Day 2 post-debridement, patient remains febrile with rising lactate.

— Answer: Return to OR for re-exploration — not just broader antibiotics.

— Stem: 85yo with extensive Fournier, multiorgan failure, surrogate uncertain about further surgery.

— Answer: Palliative care consult + family meeting to align goals; not abandonment of care.

Board pearl: When in doubt on Step 3, the answer is surgery first, antibiotics in parallel, imaging last (if at all).

Pattern 1 — Classic NSTI presentation:

Pattern 2 — Fournier gangrene:

Pattern 3 — Vibrio vulnificus:

Pattern 4 — Pediatric post-varicella:

Pattern 5 — Failed "cellulitis":

Pattern 6 — Imaging trap:

Pattern 7 — Antibiotic choice trap:

Pattern 8 — Re-exploration:

Pattern 9 — Goals of care:

One-Line Recap

Necrotizing soft tissue infection is a time-critical surgical emergency in which immediate operative debridement, broad-spectrum antibiotics including clindamycin for toxin suppression, and aggressive ICU-level resuscitation — not imaging or antibiotics alone — drive survival.

Board pearl: The most-tested error in NSTI is delaying surgery for imaging or antibiotics. Time-to-debridement is the single strongest modifiable predictor of mortality — every Step 3 stem rewards the candidate who calls surgery first.

Suspect when pain is out of proportion to exam, systemic toxicity is disproportionate to skin findings, or "cellulitis" fails 48 hours of IV antibiotics; hemorrhagic bullae, crepitus, dusky skin, or anesthesia over the lesion are hard signs.

Act with parallel pathways: 2 large-bore IVs, crystalloid resuscitation, blood cultures, lactate, vancomycin + piperacillin-tazobactam (or meropenem) + clindamycin within 1 hour, and emergent surgical consultation for OR within 6 hours — LRINEC and CT are adjuncts only, never gatekeepers, and a normal score does not rule out NSTI.

Debride widely to bleeding viable tissue, leave wounds open, plan mandatory re-exploration at 12–24 hours and every 24–48 hours until no further necrosis (average 3–5 trips); amputate if life-over-limb, divert colostomy for extensive Fournier, secure airway first in Ludwig.

Tailor to the host: Vibrio in cirrhotics (add doxycycline + ceftriaxone), invasive GAS post-varicella in kids (penicillin G + clindamycin ± IVIG), clostridial myonecrosis (penicillin G + clindamycin), polymicrobial in diabetics and IVDU; address underlying drivers (glycemic control, addiction treatment, hepatology) and coordinate transitions of care — OPAT, wound clinic at 1 week, PCP at 2 weeks, ID at antibiotic completion, plastics for reconstruction, palliative care early when prognosis is poor.